NCT05337540View on ClinicalTrials.gov

A Study to Evaluate the Efficacy, Safety and Tolerability of EVI-01 Intra-Articular Injection in Osteoarthritis of the Knee

NAActive, not recruitingINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

January 17, 2024

Primary Completion Date

October 31, 2025

Study Completion Date

October 31, 2025

Conditions

OsteoarthritisOsteoarthritis, Knee

Interventions

DEVICE

EVI-01

Single intra-articular injection of high molecular weight hyaluronic acid

DEVICE

Active comparator Synvisc-One

Single intra-articular injection of active comparator Synvisc-One

Trial Locations (2)

Unknown

A2Z Clinical, Valinhos

Ortocity, São Paulo

All Listed Sponsors

collaborator

Azidus Brasil

INDUSTRY

lead

Aptissen SA

INDUSTRY

NCT05337540 - A Study to Evaluate the Efficacy, Safety and Tolerability of EVI-01 Intra-Articular Injection in Osteoarthritis of the Knee | Biotech Hunter | Biotech Hunter